Charlie is driven by a singular vision: to make genetics a more empowered, collaborative science in order to fulfill the promise of the human genome and help people live healthier, better lives. In 1999, he founded Ambry Genetics because he wanted to work for a company deeply committed to restoring the balance between open science and commercial interests, one driven by pure scientists whose only pursuit is to end disease and provide the best quality service.
For 16 years since the founding of Ambry, Charlie has realized this vision by launching some of the most useful diagnostic tests, and taking on the challenge of eliminating gene patents in the precedent-setting Ambry v. Myriad case, and proceeded to share the company’s genetic data to the public, inviting collaboration with the medical research community and truly putting patients and researchers first. He believes that human life cannot be patented.
Under Charlie’s leadership, the company continues to invest in new technologies, better services, and greater collaboration to transform human health. The company has a long history of many firsts-to-market, including being the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. Today, Ambry is the premier clinical molecular diagnostic laboratory and remains led by scientists, offering the most comprehensive suite of genetic testing solutions for inherited and non-inherited diseases.
Two years ago Charlie found he had stage four cancer. Now in remission, Charlie remains deeply connected to the mind and hearts of patients, understanding that access to information is just as important as quality science in finding the best treatment.
Charlie is a graduate of the University of California, San Diego with concentrations in biology, mathematics, physics, economics and history. Prior to starting Ambry, he worked with some of the top academic and commercial laboratories in the world, including the Scripps Research Institute in La Jolla, California. In 2015, Charlie was a recipient of Ernst & Young’s Entrepreneur of the Year award. Along with Ambry, Charlie also founded the Mauli Ola Foundation, a non-profit organization that brings his passion for surfing and the ocean to people living with genetic disorders.